RP 72540

a CCK(B) receptor antagonist; structure in first source

Also Known As:

2-(3-(3-(N-(3-methoxyphenyl)-N-(N-methyl-N-phenylcarbamoylmethyl)carbamoylmethyl)ureido)phenyl)propionic acid; RP-72540; RP72540; RPR 101048; RPR 102681; RPR-101048; RPR-102681; RPR101048; RPR102681

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Brašić, James Robert: 1 article (01/2019)
2.	Cantelina, Louis R: 1 article (01/2019)
3.	Chiang, Nora: 1 article (01/2019)
4.	Crabb, Andrew: 1 article (01/2019)
5.	Elkashef, Ahmed: 1 article (01/2019)
6.	Hilton, John: 1 article (01/2019)
7.	Kahn, Roberta: 1 article (01/2019)
8.	Mojsiak, Jurij: 1 article (01/2019)
9.	Vocci, Frank: 1 article (01/2019)
10.	Warren, Kimberly R: 1 article (01/2019)

Related Diseases

1.	Hyperemia 01/01/2001 - "These secretory, protective, hipergastrinemic and hyperemic effects of N alpha-MH and histamine were completely abolished by antrectomy, whereas pretreatment with RPR 102681 attenuated significantly the N alpha-MH and histamine-induced protection against ethanol damage and accompanying hyperemia. "
2.	Cocaine-Related Disorders (Cocaine Addiction) 01/01/2019 - "Overall, this pilot study suggests that RPR 102681 would be unlikely candidate, as an agonist medication for the treatment for cocaine addiction but worth investigating further for possible role in reducing craving."

Related Drugs and Biologics

1.	Histamine (Histamine Dihydrochloride)
2.	Ethanol (Ethyl Alcohol)